IL324918A - תרופות פסיכואקטיביות ושימושן בטיפול במצבים והפרעות פסיכיאטריות ונוירולוגיות - Google Patents

תרופות פסיכואקטיביות ושימושן בטיפול במצבים והפרעות פסיכיאטריות ונוירולוגיות

Info

Publication number
IL324918A
IL324918A IL324918A IL32491825A IL324918A IL 324918 A IL324918 A IL 324918A IL 324918 A IL324918 A IL 324918A IL 32491825 A IL32491825 A IL 32491825A IL 324918 A IL324918 A IL 324918A
Authority
IL
Israel
Prior art keywords
methylone
subject
disorder
agonist
neuropsychiatric illness
Prior art date
Application number
IL324918A
Other languages
English (en)
Inventor
Blake Mandell
Martin Stogniew
Jennifer Louise Schmidt
Markus Seelig
Original Assignee
Transcend Therapeutics Inc
Blake Mandell
Martin Stogniew
Jennifer Louise Schmidt
Markus Seelig
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transcend Therapeutics Inc, Blake Mandell, Martin Stogniew, Jennifer Louise Schmidt, Markus Seelig filed Critical Transcend Therapeutics Inc
Priority claimed from PCT/US2024/032615 external-priority patent/WO2024254190A2/en
Publication of IL324918A publication Critical patent/IL324918A/he

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
IL324918A 2023-06-06 2024-06-05 תרופות פסיכואקטיביות ושימושן בטיפול במצבים והפרעות פסיכיאטריות ונוירולוגיות IL324918A (he)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202363471412P 2023-06-06 2023-06-06
US202363602904P 2023-11-27 2023-11-27
US202363605729P 2023-12-04 2023-12-04
US202363607702P 2023-12-08 2023-12-08
US202463553788P 2024-02-15 2024-02-15
US202463649653P 2024-05-20 2024-05-20
PCT/US2024/032615 WO2024254190A2 (en) 2023-06-06 2024-06-05 Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders

Publications (1)

Publication Number Publication Date
IL324918A true IL324918A (he) 2026-01-01

Family

ID=98099691

Family Applications (1)

Application Number Title Priority Date Filing Date
IL324918A IL324918A (he) 2023-06-06 2024-06-05 תרופות פסיכואקטיביות ושימושן בטיפול במצבים והפרעות פסיכיאטריות ונוירולוגיות

Country Status (5)

Country Link
EP (1) EP4724433A2 (he)
KR (1) KR20260053276A (he)
AU (1) AU2024284688A1 (he)
IL (1) IL324918A (he)
MX (1) MX2025014366A (he)

Also Published As

Publication number Publication date
EP4724433A2 (en) 2026-04-15
AU2024284688A1 (en) 2025-12-11
MX2025014366A (es) 2026-02-03
KR20260053276A (ko) 2026-04-21

Similar Documents

Publication Publication Date Title
US20250302851A1 (en) Methods of treating neurocognitive disorders, chronic pain and reducing inflammation
US11969407B2 (en) Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders
US12295937B2 (en) Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders
WO2023081895A1 (en) Isotopically enriched analogs of 5,6-methylenedioxy-2-aminoindane (mdai)
US12343326B2 (en) Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders
TW202345789A (zh) 精神作用醫藥及其用於治療精神及神經病狀及病症之用途
US20260130884A1 (en) Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders
US20250332139A1 (en) Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders
WO2024254190A2 (en) Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders
AU2024284688A1 (en) Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders
US20250221957A1 (en) Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders
HK40120411A (zh) 精神作用药物及其用於治疗精神和神经病状和病症的用途
HK40112015A (zh) 精神作用药物及其用於治疗精神和神经病状和病症的用途
CN118434416A (zh) 精神作用药物及其用于治疗精神和神经病状和病症的用途